(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are MongoDB, Hoth Therapeutics, and Kintara Therapeutics.

The three biggest losers today are Akerna Corp., HighPeak Energy, and HOOKIPA Pharma.

Winners today

1. MongoDB (MDB) – 27.5%

MongoDB, Inc. provides general purpose database platform worldwide. The company offers MongoDB Atlas, a hosted multi-cloud database-as-a-service solution; MongoDB Enterprise Advanced, a commercial database server for enterprise customers to run in the cloud, on-premise, or in a hybrid environment; and Community Server, a free-to-download version of its database, which includes the functionality that developers need to get started with MongoDB. It also provides professional services comprising consulting and training. The company was formerly known as 10gen, Inc. and changed its name to MongoDB, Inc. in August 2013. MongoDB, Inc. was incorporated in 2007 and is headquartered in New York, New York.

NASDAQ ended the session with MongoDB jumping 27.5% to $374.79 on Friday, after three sequential sessions in a row of gains. NASDAQ rose 1.07% to $13,240.77, following the last session’s upward trend on what was an all-around bullish trend exchanging session today.

Mongodb stock news and forecast: MDB adds $6 billion to market cap with 27% earnings rallyWall Street analysts had placed their consensus for $0.19, but instead MongoDB brought home nearly three times as much at $0.56 per share.

Earnings Per Share

As for profitability, MongoDB has a trailing twelve months EPS of $-5.03.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -49.13%.

Moving Average

MongoDB’s worth is way above its 50-day moving average of $238.12 and way above its 200-day moving average of $218.63.

Yearly Top and Bottom Value

MongoDB’s stock is valued at $374.79 at 17:32 EST, below its 52-week high of $390.84 and way above its 52-week low of $135.15.

Revenue Growth

Year-on-year quarterly revenue growth grew by 35.6%, now sitting on 1.28B for the twelve trailing months.

Previous days news about MongoDB

• Mongodb (mdb) Q1 earnings and revenues surpass estimates. According to Zacks on Thursday, 1 June, "While MongoDB has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"

More news about MongoDB.

2. Hoth Therapeutics (HOTH) – 20.25%

Hoth Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for dermatological disorders. The company focuses on therapies for patients suffering from indications, including eczema, chronic wounds, psoriasis, asthma, and acne. Its pipeline portfolio includes HT-001, a topical formulation for the treatment of mild to moderate rash and skin disorders associated with initial and repeat courses of tyrosine kinase inhibitor/epidermal growth factor receptor (EGFR) inhibitor therapy; HT-002 to treat illness associated with SARS-CoV-2 infection; HT-003D for the topical treatment in acne and psoriasis applications; HT-003IB to treat inflammatory bowel diseases; HT-004 for the treatment of asthma, atopic dermatitis, and other allergic diseases; HT-005 Z-PODS to treat cutaneous lupus erythematosus; HT-006 for treatment of multiple bacterial pathogens. The company has license agreements with the George Washington University; the University of Maryland; Isoprene Pharmaceuticals, Inc.; the North Carolina State University; Chelexa BioSciences, Inc.; and the University of Cincinnati. It also has a partnership agreement with Zylö Therapeutics Inc. co-develop a new topical treatment for patients with Cutaneous Lupus Erythematosu, a chronic autoimmune disease that affects the skin and is associated with a significant burden on patient quality of life; and research collaboration agreement with Weill Cornell Medicine to continue the advancement of HT-003 for acne treatment research. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York.

NASDAQ ended the session with Hoth Therapeutics rising 20.25% to $1.90 on Friday, following the last session’s upward trend. NASDAQ jumped 1.07% to $13,240.77, following the last session’s upward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, Hoth Therapeutics has a trailing twelve months EPS of $-7.7.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -111.23%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 34.6% and 68.7%, respectively.

Yearly Top and Bottom Value

Hoth Therapeutics’s stock is valued at $1.90 at 17:32 EST, way below its 52-week high of $17.50 and way higher than its 52-week low of $1.52.

Volume

Today’s last reported volume for Hoth Therapeutics is 2709620 which is 1096.28% above its average volume of 226504.

Moving Average

Hoth Therapeutics’s worth is above its 50-day moving average of $1.84 and way below its 200-day moving average of $4.89.

More news about Hoth Therapeutics.

3. Kintara Therapeutics (KTRA) – 17.8%

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a photodynamic therapy for the treatment of cutaneous metastatic breast cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was founded in 2009 and is headquartered in San Diego, California.

NASDAQ ended the session with Kintara Therapeutics rising 17.8% to $3.64 on Friday, following the last session’s downward trend. NASDAQ jumped 1.07% to $13,240.77, following the last session’s upward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, Kintara Therapeutics has a trailing twelve months EPS of $-11.2.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -254.48%.

Yearly Top and Bottom Value

Kintara Therapeutics’s stock is valued at $3.64 at 17:32 EST, way below its 52-week high of $20.00 and way higher than its 52-week low of $2.70.

More news about Kintara Therapeutics.

4. DISH Network (DISH) – 16.8%

DISH Network Corporation, together with its subsidiaries, provides pay-TV services in the United States. The company operates in two segments, Pay-TV and Wireless. It offers video services under the DISH TV brand; and programming packages that include programming through national broadcast networks, local broadcast networks, and national and regional cable networks, as well as regional and specialty sports channels, premium movie channels, and Latino and international programming packages. The company also provides access to movies and television shows through TV or Internet-connected devices; and dishanywhere.com and mobile applications on Internet-connected devices to view authorized content, search program listings, and remotely control certain features of their DVRs. In addition, it offers Sling TV services, including Sling domestic, Sling International, Sling Latino, Sling Orange, and Sling Blue services that require an internet connection and are available on streaming-capable devices, such as streaming media devices, TVs, tablets, computers, game consoles, and phones, as well as market SLING TV services to consumers who do not subscribe to traditional satellite and cable pay-TV services. Further, the company provides wireless subscribers consumer plans with no annual service contracts, as well as monthly service plans, including high-speed data and unlimited talk and text. The company offers receiver systems and programming through direct sales channels, as well as independent third parties, such as small retailers, direct marketing groups, local and regional consumer electronics stores, retailers, and telecommunications companies. DISH Network Corporation was founded in 1980 and is headquartered in Englewood, Colorado.

NASDAQ ended the session with DISH Network jumping 16.8% to $7.34 on Friday while NASDAQ rose 1.07% to $13,240.77.

Earnings Per Share

As for profitability, DISH Network has a trailing twelve months EPS of $3.2.

PE Ratio

DISH Network has a trailing twelve months price to earnings ratio of 2.29. Meaning, the purchaser of the share is investing $2.29 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.36%.

Moving Average

DISH Network’s worth is under its 50-day moving average of $8.05 and way below its 200-day moving average of $13.41.

Volume

Today’s last reported volume for DISH Network is 39969000 which is 296.79% above its average volume of 10072900.

Yearly Top and Bottom Value

DISH Network’s stock is valued at $7.34 at 17:32 EST, way under its 52-week high of $23.49 and way higher than its 52-week low of $5.94.

More news about DISH Network.

5. International General Insurance Holdings Ltd. (IGICW) – 13.33%

NASDAQ ended the session with International General Insurance Holdings Ltd. rising 13.33% to $0.68 on Friday, after five sequential sessions in a row of losses. NASDAQ rose 1.07% to $13,240.77, following the last session’s upward trend on what was an all-around up trend exchanging session today.

Yearly Top and Bottom Value

International General Insurance Holdings Ltd.’s stock is valued at $0.68 at 17:32 EST, under its 52-week low of $0.68.

More news about International General Insurance Holdings Ltd..

6. Kodiak Sciences (KOD) – 12.91%

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in researching, developing, and commercializing therapeutics to treat retinal diseases in the United States and international markets. Its lead product candidate is KSI-301, a vascular endothelial growth factor (VEGF)-biological agent that is in Phase 1b clinical study to treat wet age-related macular degeneration (AMD) and diabetic retinopathy, including diabetic macular edema, as well as for macular edema due to retinal vein occlusion. The company's preclinical stage product candidate includes KSI-501, a bispecific anti-interleukin 6/VEGF bioconjugate conjugate to treat neovascular retinal diseases with an inflammatory component. Its early research pipeline includes KSI-601, a triplet inhibitor for the treatment of multifactorial retinal diseases, such as dry AMD and the neurodegenerative aspects of glaucoma. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was founded in 2009 and is based in Palo Alto, California.

NASDAQ ended the session with Kodiak Sciences jumping 12.91% to $7.17 on Friday while NASDAQ jumped 1.07% to $13,240.77.

Earnings Per Share

As for profitability, Kodiak Sciences has a trailing twelve months EPS of $-6.33.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -62.4%.

More news about Kodiak Sciences.

7. Kaixin Auto Holdings (KXIN) – 12.73%

Kaixin Auto Holdings operates as a used car dealership in the People's Republic of China. As of December 31, 2020, the company had 14 dealerships. It also provides financing channels to its customers through its partnership with financial institutions; and value-added services to its customers, including insurance, extended warranties, and after-sales services. The company was founded in 2015 and is headquartered in Beijing, the People's Republic of China. Kaixin Auto Holdings is a subsidiary of Renren Inc.

NASDAQ ended the session with Kaixin Auto Holdings jumping 12.73% to $0.34 on Friday, following the last session’s upward trend. NASDAQ rose 1.07% to $13,240.77, following the last session’s upward trend on what was an all-around positive trend exchanging session today.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -230%.

More news about Kaixin Auto Holdings.

8. 3D Systems (DDD) – 10.55%

3D Systems Corporation provides 3D printing and digital manufacturing solutions in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers 3D printers technologies, such as stereolithography, selective laser sintering, direct metal printing, multi jet printing, color jet printing, polymer extrusion, and extrusion and SLA based bioprinting that transform digital data input generated by 3D design software, computer aided design (CAD) software, or other 3D design tools into printed parts. It also develops, blends, and markets various print materials, such as plastic, nylon, metal, composite, elastomeric, wax, polymeric dental materials, and biocompatible materials. In addition, the company provides digital design tools, including software, scanners, and haptic devices, as well as solutions for product design, simulation, mold and die design, 3D scan-to-print, reverse engineering, production machining, metrology, and inspection and manufacturing workflows under the Geomagic brand. Further, it offers 3D Sprint and 3DXpert, a proprietary software to prepare and optimize CAD data and manage the additive manufacturing processes, which provides automated support building and placement, build platform management, print simulation, and print queue management; and Bioprint Pro, a software solution that allows researchers to design and bioprint repeatable experiments. Additionally, the company provides maintenance and training services; manufacturing services; and software and precision healthcare services. It primarily serves companies and small and midsize businesses in medical, dental, automotive, aerospace, durable goods, government, defense, technology, jewelry, electronic, education, consumer goods, energy, biotechnology, and other industries through direct sales force, channel partners, and appointed distributors. 3D Systems Corporation was founded in 1986 and is headquartered in Rock Hill, South Carolina.

NYSE ended the session with 3D Systems jumping 10.55% to $9.21 on Friday, after three sequential sessions in a row of gains. NYSE rose 2.13% to $15,351.96, following the last session’s upward trend on what was an all-around bullish trend exchanging session today.

Earnings Per Share

As for profitability, 3D Systems has a trailing twelve months EPS of $-1.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.13%.

Sales Growth

3D Systems’s sales growth is negative 3.9% for the ongoing quarter and 1.7% for the next.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 28.6% and 40%, respectively.

More news about 3D Systems.

9. 3D Systems (DDD) – 10.55%

3D Systems Corporation provides 3D printing and digital manufacturing solutions in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers 3D printers technologies, such as stereolithography, selective laser sintering, direct metal printing, multi jet printing, color jet printing, polymer extrusion, and extrusion and SLA based bioprinting that transform digital data input generated by 3D design software, computer aided design (CAD) software, or other 3D design tools into printed parts. It also develops, blends, and markets various print materials, such as plastic, nylon, metal, composite, elastomeric, wax, polymeric dental materials, and biocompatible materials. In addition, the company provides digital design tools, including software, scanners, and haptic devices, as well as solutions for product design, simulation, mold and die design, 3D scan-to-print, reverse engineering, production machining, metrology, and inspection and manufacturing workflows under the Geomagic brand. Further, it offers 3D Sprint and 3DXpert, a proprietary software to prepare and optimize CAD data and manage the additive manufacturing processes, which provides automated support building and placement, build platform management, print simulation, and print queue management; and Bioprint Pro, a software solution that allows researchers to design and bioprint repeatable experiments. Additionally, the company provides maintenance and training services; manufacturing services; and software and precision healthcare services. It primarily serves companies and small and midsize businesses in medical, dental, automotive, aerospace, durable goods, government, defense, technology, jewelry, electronic, education, consumer goods, energy, biotechnology, and other industries through direct sales force, channel partners, and appointed distributors. 3D Systems Corporation was founded in 1986 and is headquartered in Rock Hill, South Carolina.

NYSE ended the session with 3D Systems jumping 10.55% to $9.21 on Friday while NYSE jumped 2.13% to $15,351.96.

Earnings Per Share

As for profitability, 3D Systems has a trailing twelve months EPS of $-1.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.13%.

Yearly Top and Bottom Value

3D Systems’s stock is valued at $9.21 at 17:32 EST, way under its 52-week high of $13.52 and way higher than its 52-week low of $7.02.

Earnings Before Interest, Taxes, Depreciation, and Amortization

3D Systems’s EBITDA is 2.02.

Revenue Growth

Year-on-year quarterly revenue growth declined by 8.8%, now sitting on 526.27M for the twelve trailing months.

More news about 3D Systems.

10. Groupon (GRPN) – 10.28%

Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants; and first-party goods inventory. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.

NASDAQ ended the session with Groupon jumping 10.28% to $5.95 on Friday while NASDAQ jumped 1.07% to $13,240.77.

Earnings Per Share

As for profitability, Groupon has a trailing twelve months EPS of $-7.49.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -285.15%.

Yearly Top and Bottom Value

Groupon’s stock is valued at $5.95 at 17:32 EST, way below its 52-week high of $16.45 and way above its 52-week low of $2.89.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Groupon’s stock is considered to be overbought (>=80).

More news about Groupon.

Losers Today

1. Akerna Corp. (KERNW) – -44.25%

NASDAQ ended the session with Akerna Corp. falling 44.25% to $0.01 on Friday, after five sequential sessions in a row of losses. NASDAQ rose 1.07% to $13,240.77, following the last session’s upward trend on what was an all-around up trend trading session today.

Yearly Top and Bottom Value

Akerna Corp.’s stock is valued at $0.01 at 17:32 EST, way under its 52-week high of $0.01 and way above its 52-week low of $0.01.

More news about Akerna Corp..

2. HighPeak Energy (HPKEW) – -14.8%

NASDAQ ended the session with HighPeak Energy falling 14.8% to $9.21 on Friday, after three successive sessions in a row of losses. NASDAQ jumped 1.07% to $13,240.77, following the last session’s upward trend on what was an all-around up trend trading session today.

Volume

Today’s last reported volume for HighPeak Energy is 5672 which is 126.24% above its average volume of 2507.

Moving Average

HighPeak Energy’s value is way under its 50-day moving average of $14.23 and way below its 200-day moving average of $15.20.

More news about HighPeak Energy.

3. HOOKIPA Pharma (HOOK) – -14.5%

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop infectious disease product candidates intended to support functional cures for chronic Hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was incorporated in 2011 and is headquartered in New York, New York.

NASDAQ ended the session with HOOKIPA Pharma dropping 14.5% to $1.12 on Friday, after two successive sessions in a row of losses. NASDAQ jumped 1.07% to $13,240.77, following the last session’s upward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, HOOKIPA Pharma has a trailing twelve months EPS of $-0.93.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -57.58%.

Volume

Today’s last reported volume for HOOKIPA Pharma is 8640410 which is 735.64% above its average volume of 1033980.

Moving Average

HOOKIPA Pharma’s value is higher than its 50-day moving average of $1.10 and higher than its 200-day moving average of $1.11.

Sales Growth

HOOKIPA Pharma’s sales growth for the current quarter is 77.3%.

More news about HOOKIPA Pharma.

4. Jaguar Health (JAGX) – -14.13%

Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. It operates through two reportable segments, Human Health and Animal Health. The company, through its subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human gastrointestinal pharmaceuticals from plants harvested responsibly from rainforest areas. It markets Mytesi, a crofelemer 125 mg delayed-release tablet for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. It develops Mytesi for multiple possible follow-on indications, including diarrhea related to targeted cancer therapy; orphan-drug indications for infants and children with congenital diarrheal disorders and short bowel syndrome; supportive care for inflammatory bowel disease; irritable bowel syndrome; and for idiopathic/functional diarrhea, as well as a second-generation proprietary anti-secretory agent is in development for cholera. The company also develops Crofelemer, a drug product candidate for chemotherapy-induced diarrhea in dogs. Jaguar Health, Inc. was incorporated in 2013 and is headquartered in San Francisco, California.

NASDAQ ended the session with Jaguar Health sliding 14.13% to $0.57 on Friday, after three sequential sessions in a row of losses. NASDAQ jumped 1.07% to $13,240.77, following the last session’s upward trend on what was an all-around bullish trend exchanging session today.

Earnings Per Share

As for profitability, Jaguar Health has a trailing twelve months EPS of $-14.13.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -540.66%.

Sales Growth

Jaguar Health’s sales growth for the current quarter is 56.7%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Jaguar Health’s EBITDA is 3.41.

More news about Jaguar Health.

5. Kymera Therapeutics (KYMR) – -11.05%

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; and STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases. The company was founded in 2015 and is headquartered in Watertown, Massachusetts.

NASDAQ ended the session with Kymera Therapeutics sliding 11.05% to $26.15 on Friday while NASDAQ jumped 1.07% to $13,240.77.

Earnings Per Share

As for profitability, Kymera Therapeutics has a trailing twelve months EPS of $-2.88.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -35.71%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 7.7% and 20.3%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.6%, now sitting on 46.67M for the twelve trailing months.

Volume

Today’s last reported volume for Kymera Therapeutics is 1162980 which is 163.12% above its average volume of 441988.

More news about Kymera Therapeutics.

6. Matterport
(MTTR) – -9.76%

Matterport, Inc., a spatial data company, focuses on digitization and datafication of the built world. The company offers Matterport Capture Services, a fully managed solution for enterprise subscribers; Smartphone Capture, a smartphone capture solution for both iOS and Android; Matterport Pro3, a 3D camera that scans properties; Matterport Pro2, a 3D camera that captures spaces; and 360 Cameras. It also provides Matterport Axis, a motorized mount that can be used with the Matterport Capture app to capture 3D digital twins of any physical space with increased speed, precision, and consistency. It offers solutions for residential and commercial real estate, facilities management and retail, AEC, insurance and repair, and travel and hospitality. Matterport, Inc. is headquartered in Sunnyvale, California.

NASDAQ ended the session with Matterport
sliding 9.76% to $2.64 on Friday while NASDAQ jumped 1.07% to $13,240.77.

Earnings Per Share

As for profitability, Matterport
has a trailing twelve months EPS of $-0.84.

Volume

Today’s last reported volume for Matterport
is 8217650 which is 200.92% above its average volume of 2730810.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 33.3% and 11.1%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Matterport
‘s EBITDA is -5.34.

Volatility

Matterport
‘s last week, last month’s, and last quarter’s current intraday variation average was 3.74%, 1.61%, and 3.07%.

Matterport
‘s highest amplitude of average volatility was 3.74% (last week), 2.84% (last month), and 3.07% (last quarter).

More news about Matterport
.

7. Matterport
(MTTR) – -9.76%

Matterport, Inc., a spatial data company, focuses on digitization and datafication of the built world. The company offers Matterport Capture Services, a fully managed solution for enterprise subscribers; Smartphone Capture, a smartphone capture solution for both iOS and Android; Matterport Pro3, a 3D camera that scans properties; Matterport Pro2, a 3D camera that captures spaces; and 360 Cameras. It also provides Matterport Axis, a motorized mount that can be used with the Matterport Capture app to capture 3D digital twins of any physical space with increased speed, precision, and consistency. It offers solutions for residential and commercial real estate, facilities management and retail, AEC, insurance and repair, and travel and hospitality. Matterport, Inc. is headquartered in Sunnyvale, California.

NASDAQ ended the session with Matterport
falling 9.76% to $2.64 on Friday, after two successive sessions in a row of losses. NASDAQ jumped 1.07% to $13,240.77, following the last session’s upward trend on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, Matterport
has a trailing twelve months EPS of $-0.84.

Sales Growth

Matterport
‘s sales growth is 37.8% for the current quarter and 16.2% for the next.

More news about Matterport
.

8. T-Mobile (TMUS) – -6.7%

T-Mobile US, Inc., together with its subsidiaries, provides mobile communications services in the United States, Puerto Rico, and the United States Virgin Islands. The company offers voice, messaging, and data services to customers in the postpaid, prepaid, and wholesale and other services. It also provides wireless devices, including smartphones, wearables, tablets, home broadband routers, and other mobile communication devices, as well as wireless devices and accessories; financing through equipment installment plans; leasing through JUMP! On Demand; and High Speed Internet services. In addition, the company offers services, devices, and accessories under the T-Mobile and Metro by T-Mobile brands through its owned and operated retail stores, T-Mobile app and customer care channels, and its websites. It also sells its devices to dealers and other third-party distributors for resale through independent third-party retail outlets and various third-party websites. The company was founded in 1994 and is headquartered in Bellevue, Washington.

NASDAQ ended the session with T-Mobile dropping 6.7% to $129.60 on Friday while NASDAQ jumped 1.07% to $13,240.77.

Earnings Per Share

As for profitability, T-Mobile has a trailing twelve months EPS of $3.11.

PE Ratio

T-Mobile has a trailing twelve months price to earnings ratio of 41.67. Meaning, the purchaser of the share is investing $41.67 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.58%.

Yearly Top and Bottom Value

T-Mobile’s stock is valued at $129.60 at 17:32 EST, way under its 52-week high of $154.38 and above its 52-week low of $121.76.

Earnings Before Interest, Taxes, Depreciation, and Amortization

T-Mobile’s EBITDA is 3.51.

Volume

Today’s last reported volume for T-Mobile is 32166600 which is 464.58% above its average volume of 5697410.

More news about T-Mobile.

9. 9F (JFU) – -6.41%

9F Inc., together with its subsidiaries, operates a digital financial account platform that integrates and personalizes financial services in the People's Republic of China. Its products include digital financial accounts that offer online lending, online wealth management, and payment facilitation services; revolving and non-revolving loan products to borrowers, as well as traffic referral services to institutional funding partners; and a suite of online wealth management products, such as fixed income products, stocks, insurance, and mutual funds to investors in various platforms, including Wukong Licai, 9F Wallet, and 9F Puhui. The company also provides payment facilitation and other products and services that help users to pay credit card bills and household bills, such as utility bills; and other value-added services, including credit history search, debt consolidation, and user referral services. It has partnerships with borrowers, investors, financial institutions, and merchant partners. The company was formerly known as JIUFU Financial Technology Service Limited and changed its name to 9F Inc. in June 2014. 9F Inc. was founded in 2006 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with 9F dropping 6.41% to $4.80 on Friday, following the last session’s downward trend. NASDAQ jumped 1.07% to $13,240.77, following the last session’s upward trend on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, 9F has a trailing twelve months EPS of $-6.7.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.06%.

Volume

Today’s last reported volume for 9F is 930 which is 97% below its average volume of 31098.

Revenue Growth

Year-on-year quarterly revenue growth declined by 36.5%, now sitting on 561.67M for the twelve trailing months.

More news about 9F.

10. Riot Blockchain (RIOT) – -5.68%

Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. It operates through Bitcoin Mining, Data Center Hosting, and Engineering segments. The company also provides co-location services for institutional-scale bitcoin mining companies; and critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners. In addition, it engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy; operation of data centers; and maintenance/management of computing capacity. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.

NASDAQ ended the session with Riot Blockchain sliding 5.68% to $11.70 on Friday while NASDAQ jumped 1.07% to $13,240.77.

Earnings Per Share

As for profitability, Riot Blockchain has a trailing twelve months EPS of $-4.44.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.54%.

More news about Riot Blockchain.

Stay up to date with our winners and losers daily report